_version_ 1785090443415912448
author Hasselmann, Rebecca
Blümel, Lena
Bernardi, Flavia
Picard, Daniel
Torrejon-Diaz, Jacob
Jepsen, Vera
Bartl, Jasmin
Qin, Nan
Bornhauser, Beat
Bhatia, Sanil
Marovca, Blerim
Marsaud, Veronique
Dingli, Florent
Loew, Damarys
Stanulla, Martin
Bourquin, Jean-Pierre
Borkhardt, Arndt
Remke, Marc
Ayrault, Olivier
Fischer, Ute
author_facet Hasselmann, Rebecca
Blümel, Lena
Bernardi, Flavia
Picard, Daniel
Torrejon-Diaz, Jacob
Jepsen, Vera
Bartl, Jasmin
Qin, Nan
Bornhauser, Beat
Bhatia, Sanil
Marovca, Blerim
Marsaud, Veronique
Dingli, Florent
Loew, Damarys
Stanulla, Martin
Bourquin, Jean-Pierre
Borkhardt, Arndt
Remke, Marc
Ayrault, Olivier
Fischer, Ute
author_sort Hasselmann, Rebecca
collection PubMed
description
format Online
Article
Text
id pubmed-10428333
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Lippincott Williams & Wilkins
record_format MEDLINE/PubMed
spelling pubmed-104283332023-08-17 P330: PROTEOMIC PROFILING UNCOVERS THERAPEUTIC VULNERABILITIES FOR TCF3 TRANSLOCATED B-CELL ACUTE LYMPHOBLASTIC LEUKEMIAS Hasselmann, Rebecca Blümel, Lena Bernardi, Flavia Picard, Daniel Torrejon-Diaz, Jacob Jepsen, Vera Bartl, Jasmin Qin, Nan Bornhauser, Beat Bhatia, Sanil Marovca, Blerim Marsaud, Veronique Dingli, Florent Loew, Damarys Stanulla, Martin Bourquin, Jean-Pierre Borkhardt, Arndt Remke, Marc Ayrault, Olivier Fischer, Ute Hemasphere Posters Lippincott Williams & Wilkins 2023-08-08 /pmc/articles/PMC10428333/ http://dx.doi.org/10.1097/01.HS9.0000968232.58087.8c Text en Copyright © 2023 The Author(s). Published by Wolters Kluwer Health, Inc. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access Abstract Book distributed under the Attribution-NonCommercial-NoDerivs (CC BY-NC-ND) (https://creativecommons.org/licenses/by-nc-nd/4.0/) which allows third parties to download the articles and share them with others as long as they credit the author and the Abstract Book, but they cannot change the content in any way or use them commercially.
spellingShingle Posters
Hasselmann, Rebecca
Blümel, Lena
Bernardi, Flavia
Picard, Daniel
Torrejon-Diaz, Jacob
Jepsen, Vera
Bartl, Jasmin
Qin, Nan
Bornhauser, Beat
Bhatia, Sanil
Marovca, Blerim
Marsaud, Veronique
Dingli, Florent
Loew, Damarys
Stanulla, Martin
Bourquin, Jean-Pierre
Borkhardt, Arndt
Remke, Marc
Ayrault, Olivier
Fischer, Ute
P330: PROTEOMIC PROFILING UNCOVERS THERAPEUTIC VULNERABILITIES FOR TCF3 TRANSLOCATED B-CELL ACUTE LYMPHOBLASTIC LEUKEMIAS
title P330: PROTEOMIC PROFILING UNCOVERS THERAPEUTIC VULNERABILITIES FOR TCF3 TRANSLOCATED B-CELL ACUTE LYMPHOBLASTIC LEUKEMIAS
title_full P330: PROTEOMIC PROFILING UNCOVERS THERAPEUTIC VULNERABILITIES FOR TCF3 TRANSLOCATED B-CELL ACUTE LYMPHOBLASTIC LEUKEMIAS
title_fullStr P330: PROTEOMIC PROFILING UNCOVERS THERAPEUTIC VULNERABILITIES FOR TCF3 TRANSLOCATED B-CELL ACUTE LYMPHOBLASTIC LEUKEMIAS
title_full_unstemmed P330: PROTEOMIC PROFILING UNCOVERS THERAPEUTIC VULNERABILITIES FOR TCF3 TRANSLOCATED B-CELL ACUTE LYMPHOBLASTIC LEUKEMIAS
title_short P330: PROTEOMIC PROFILING UNCOVERS THERAPEUTIC VULNERABILITIES FOR TCF3 TRANSLOCATED B-CELL ACUTE LYMPHOBLASTIC LEUKEMIAS
title_sort p330: proteomic profiling uncovers therapeutic vulnerabilities for tcf3 translocated b-cell acute lymphoblastic leukemias
topic Posters
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10428333/
http://dx.doi.org/10.1097/01.HS9.0000968232.58087.8c
work_keys_str_mv AT hasselmannrebecca p330proteomicprofilinguncoverstherapeuticvulnerabilitiesfortcf3translocatedbcellacutelymphoblasticleukemias
AT blumellena p330proteomicprofilinguncoverstherapeuticvulnerabilitiesfortcf3translocatedbcellacutelymphoblasticleukemias
AT bernardiflavia p330proteomicprofilinguncoverstherapeuticvulnerabilitiesfortcf3translocatedbcellacutelymphoblasticleukemias
AT picarddaniel p330proteomicprofilinguncoverstherapeuticvulnerabilitiesfortcf3translocatedbcellacutelymphoblasticleukemias
AT torrejondiazjacob p330proteomicprofilinguncoverstherapeuticvulnerabilitiesfortcf3translocatedbcellacutelymphoblasticleukemias
AT jepsenvera p330proteomicprofilinguncoverstherapeuticvulnerabilitiesfortcf3translocatedbcellacutelymphoblasticleukemias
AT bartljasmin p330proteomicprofilinguncoverstherapeuticvulnerabilitiesfortcf3translocatedbcellacutelymphoblasticleukemias
AT qinnan p330proteomicprofilinguncoverstherapeuticvulnerabilitiesfortcf3translocatedbcellacutelymphoblasticleukemias
AT bornhauserbeat p330proteomicprofilinguncoverstherapeuticvulnerabilitiesfortcf3translocatedbcellacutelymphoblasticleukemias
AT bhatiasanil p330proteomicprofilinguncoverstherapeuticvulnerabilitiesfortcf3translocatedbcellacutelymphoblasticleukemias
AT marovcablerim p330proteomicprofilinguncoverstherapeuticvulnerabilitiesfortcf3translocatedbcellacutelymphoblasticleukemias
AT marsaudveronique p330proteomicprofilinguncoverstherapeuticvulnerabilitiesfortcf3translocatedbcellacutelymphoblasticleukemias
AT dingliflorent p330proteomicprofilinguncoverstherapeuticvulnerabilitiesfortcf3translocatedbcellacutelymphoblasticleukemias
AT loewdamarys p330proteomicprofilinguncoverstherapeuticvulnerabilitiesfortcf3translocatedbcellacutelymphoblasticleukemias
AT stanullamartin p330proteomicprofilinguncoverstherapeuticvulnerabilitiesfortcf3translocatedbcellacutelymphoblasticleukemias
AT bourquinjeanpierre p330proteomicprofilinguncoverstherapeuticvulnerabilitiesfortcf3translocatedbcellacutelymphoblasticleukemias
AT borkhardtarndt p330proteomicprofilinguncoverstherapeuticvulnerabilitiesfortcf3translocatedbcellacutelymphoblasticleukemias
AT remkemarc p330proteomicprofilinguncoverstherapeuticvulnerabilitiesfortcf3translocatedbcellacutelymphoblasticleukemias
AT ayraultolivier p330proteomicprofilinguncoverstherapeuticvulnerabilitiesfortcf3translocatedbcellacutelymphoblasticleukemias
AT fischerute p330proteomicprofilinguncoverstherapeuticvulnerabilitiesfortcf3translocatedbcellacutelymphoblasticleukemias